These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 32614717)
1. Letter by Weir Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2". Weir RAP Circ Res; 2020 Jul; 127(2):e44-e45. PubMed ID: 32614717 [No Abstract] [Full Text] [Related]
2. Response by Gheblawi et al to Letter Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2". Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY Circ Res; 2020 Jul; 127(2):e46-e47. PubMed ID: 32614719 [No Abstract] [Full Text] [Related]
3. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY Circ Res; 2020 May; 126(10):1456-1474. PubMed ID: 32264791 [TBL] [Abstract][Full Text] [Related]
4. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections. Speth RC Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146 [No Abstract] [Full Text] [Related]
5. Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research. Omar MB Heart Lung; 2020; 49(4):351. PubMed ID: 32327200 [No Abstract] [Full Text] [Related]
6. Angiotensin-converting enzyme-2 in SARS-CoV-2 infection: good or bad? Versmissen J; Verdonk K; Lafeber M; van den Akker JPC; Hunfeld NGM; Hoorn EJ; Danser AHJ J Hypertens; 2020 Jun; 38(6):1196-1197. PubMed ID: 32371817 [No Abstract] [Full Text] [Related]
7. [Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers]. Kreutz R; Abd El-Hady Algharably E; Ganten D; Messerli F Pneumologie; 2020 Sep; 74(9):611-614. PubMed ID: 32916743 [No Abstract] [Full Text] [Related]
8. Mechanisms by which angiotensin-receptor blockers increase ACE2 levels. Ferrario CM; Ahmad S; Groban L Nat Rev Cardiol; 2020 Jun; 17(6):378. PubMed ID: 32332868 [No Abstract] [Full Text] [Related]
9. Clinical significance of angiotensin-converting enzyme 2 receptors for severe acute respiratory syndrome coronavirus 2 (COVID-19) on peripheral small-fiber sensory neurons is unknown today. Oaklander AL Pain; 2020 Nov; 161(11):2431-2433. PubMed ID: 32826753 [No Abstract] [Full Text] [Related]
10. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2. Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system? Silhol F; Sarlon G; Deharo JC; Vaïsse B Hypertens Res; 2020 Aug; 43(8):854-856. PubMed ID: 32439915 [No Abstract] [Full Text] [Related]
12. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy? Aleksova A; Ferro F; Gagno G; Cappelletto C; Santon D; Rossi M; Ippolito G; Zumla A; Beltrami AP; Sinagra G J Intern Med; 2020 Oct; 288(4):410-421. PubMed ID: 32459372 [TBL] [Abstract][Full Text] [Related]
13. Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy. Inal JM Clin Sci (Lond); 2020 Jun; 134(12):1301-1304. PubMed ID: 32542396 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword? Yan T; Xiao R; Lin G FASEB J; 2020 May; 34(5):6017-6026. PubMed ID: 32306452 [TBL] [Abstract][Full Text] [Related]
15. [Renin-angiotensin-aldosterone blockers and Covic-19 infection : friends or enemies ?]. Pechère-Bertschi A; Ponte B; Wuerzner G Rev Med Suisse; 2020 May; 16(693):1003-1007. PubMed ID: 32401442 [TBL] [Abstract][Full Text] [Related]
16. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2? Patel AB; Verma A Clin Infect Dis; 2020 Nov; 71(16):2129-2131. PubMed ID: 32442259 [No Abstract] [Full Text] [Related]
17. [ACE2 and coronavirus - a question of balance and dynamics?]. Lundström A; Sandén P Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329 [TBL] [Abstract][Full Text] [Related]
18. [Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus]. Cano F; Gajardo M; Freundlich M Rev Chil Pediatr; 2020 Jun; 91(3):330-338. PubMed ID: 32730512 [TBL] [Abstract][Full Text] [Related]
19. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury. Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Receptor ACE2 (Angiotensin-Converting Enzyme 2) Is Upregulated in Colonic Organoids From Hypertensive Rats. Li J; Stevens BR; Richards EM; Raizada MK Hypertension; 2020 Sep; 76(3):e26-e28. PubMed ID: 32643416 [No Abstract] [Full Text] [Related] [Next] [New Search]